Co-author: Kevin Haynes
https://orcid.org/0000-0002-7087-9159
Co-authored publications (17):
- Denburg M , Li ZN , Huang J et al . Antibiotic exposure and kidney stone disease across the life course sa-po207 . Poster presented at: 2022 American Society of Nephrology Kidney Week; November 03 - November 06, 2022; Orlando, FL, US . https://www.asn-online.org/education/kidneyweek/2022/program-abstract.aspx?controlId=3768532 . doi: 10.1681/ASN.20223311S1659d .
- Hoffman P , Parlett LE , Beachler DC et al . Validation of claims-based algorithms for newly diagnosed juvenile idiopathic arthritis using machine learning methods . Poster presented at: 2023 American College of Rheumatology (ACR) Convergence; November 10 - November 15, 2023; San Diego, CA, US . https://acr23.eventscribe.net/searchGlobal.asp?mode=Presentations&SearchQuery=0353 .
- Rege S , Parlett LE , Neikirk AL et al . New diagnoses of juvenile idiopathic arthritis early in the COVID-19 pandemic analysis of a large United States commercial insurance database .J Clin Rheumatol. 2025; 31 (1) : 40-4 . doi: 10.1097/RHU.0000000000002154 .
- Garcia C , Cocoros NM , Haynes K et al . Randomized clinical trial using FDA’s Sentinel infrastructure: an analysis assessing feasibility . Podium presented at: 2017 International Society for Pharmacoepidemiology International Conference on Pharmacoepidemiology and Therapeutic Risk Management; August 26 - August 30, 2017; Montreal, QC, CA . https://www.sentinelinitiative.org/sites/default/files/Sentinel-ICPE-2017-Presentation-IMPACT-AFib.pdf .
- Long MD , Parlett LE , Lewis JD et al . Corticosteroids but not anti-TNF are associated with increased COVID-19 complications in patients with inflammatory bowel disease .Inflamm Bowel Dis. 2024; 30 (8) : 1345–52 . doi: 10.1093/ibd/izad176 .
- Adimadhyam S , Lewis JD , Simon AL et al . Real-world evidence comparing tofacitinib and vedolizumab in anti-TNF-experienced patients with ulcerative colitis .Inflamm Bowel Dis. 2024; 30 (4) : 554-62 . doi: 10.1093/ibd/izad115 .
- Horton DB , Parlett LE , Huang C et al . Jia diagnoses and trends from 2006-2019: has the U.S. ICD-9-to-ICD-10 transition created coding artifacts? . Poster presented at: 2021 American College of Rheumatology ACR Convergence; November 05 - November 09, 2021; Virtual . https://acrabstracts.org/abstract/jia-diagnoses-and-trends-from-2006-2019-has-the-u-s-icd-9-to-icd-10-transition-created-coding-artifacts/ .
- Dawwas GK , Weiss A , Constant BD et al . Development and validation of claims-based definitions to identify incident and prevalent inflammatory bowel disease in administrative healthcare databases .Inflamm Bowel Dis. 2023; 29 (12) : 1993-6 . doi: 10.1093/ibd/izad053 .
- Horton DB , Yang Y , Neikirk AL et al . Impact of the COVID-19 pandemic on the management of juvenile idiopathic arthritis: analysis of United States commercial insurance data .J Clin Rheumatol. 2023; 29 (8) : 388-95 . doi: 10.1097/RHU.0000000000002035 .
- Lewis JD , Parlett LE , Jonsson Funk ML et al . Incidence, prevalence, and racial and ethnic distribution of inflammatory bowel disease in the United States .Gastroenterology. 2023; 165 (5) : 1197-1205.e2 . doi: 10.1053/j.gastro.2023.07.003 .
- Kappelman MD , Lewis JD , Zhang X et al . Comparing patient-reported outcomes among anti-TNF-experienced patients with crohn's disease initiating vedolizumab versus ustekinumab .Dig Dis Sci. 2023; 68 (8) : 3413-20 . doi: 10.1007/s10620-023-07942-0 .
- Cocoros NM , Gurwitz J , Cziraky MJ et al . Pragmatic guidance for embedding pragmatic clinical trials in health plans: large simple trials aren't so simple .Clin Trials. 2023; 20 (4) : 416-24 . doi: 10.1177/17407745231160459 .
- Kappelman MD , Long MD , Zhang X et al . Comparing patient-reported outcomes among anti-TNF experienced patients with ulcerative colitis initiating vedolizumab versus tofacitinib .Crohns Colitis 360. 2023; 5 (3) : otad031 . doi: 10.1093/crocol/otad031 .
- Pokorney SD , Cocoros NM , Al-Khalidi HR et al . Effect of mailing educational material to patients with atrial fibrillation and their clinicians on use of oral anticoagulants: a randomized clinical trial .Jama Netw Open. 2022; 5 (5) : e221432 . doi: 10.1001/jamanetworkopen.2022.14321 .
- Al-Khatib SM , Pokorney SD , Al-Khalidi HR et al . Underuse of oral anticoagulants in privately insured patients with atrial fibrillation: a population being targeted by the implementation of a randomized controlled trial to improve treatment with oral anticoagulants in patients with atrial fibrillation (impact-afib) .Am Heart J. 2020; 229 : 110-7 . doi: 10.1016/j.ahj.2020.07.012 .
- Garcia C , Haynes K , Pokorney SD et al . Practical challenges in the conduct of pragmatic trials embedded in health plans: lessons of impact-afib, an FDA-CATALYST trial .Clin Trials. 2020; 17 (4) : 360-7 . doi: 10.1177/1740774520928426 .
- Cocoros NM , Pokorney SD , Haynes K et al . Fda-catalyst-using FDA's Sentinel initiative for large-scale pragmatic randomized trials: approach and lessons learned during the planning phase of the first trial .Clin Trials. 2019; 16 (1) : 90-7 . doi: 10.1177/1740774518812776 .